Grufity logoGrufity logo

ICUI

161.44USD-1.26(-0.77%)Market Closed

ICU Medical Inc

Market Summary

USD161.44-1.26Market Closed
-0.77%

ICUI Alerts

ICUI Stock Price

RSI Chart

Valuation

Market Cap

3.6B

Price/Earnings

653.08

Price/Sales

2

Price/Cashflow

36.14

MarketCap/EBT

-79.35

Price/Sales

Profitability

Operating Margin

26.92%

EBT Margin

-2.53%

Return on Equity

0.26%

Return on Assets

0.12%

Fundamentals

Revenue

Revenue (TTM)

2.0B

Revenue Y/Y

77.9%

Revenue Q/Q

6.57%

Earnings

Earnings (TTM)

-38.8M

Earnings Y/Y

-142.5%

Earnings Q/Q

-76.72%

Price Action

52 Week Range

128.90251.73
(Low)(High)

Last 7 days

2.5%

Last 30 days

14.5%

Last 90 days

2.6%

Trailing 12 Months

-29.0%

Financial Health

Current Ratio

2.45

Investor Care

Shares Dilution (1Y)

12.91%

Diluted EPS (TTM)

-1.56

Peers (Alternatives to ICU Medical)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
10.2T
429.9M
-11.88% 44.84%
185.5K
28.0K
144.70% 331.94%
86.7B
17.9B
14.69% -0.88%
41.71
4.92
7.67% 29.32%
86.3B
6.1B
15.30% -16.82%
62.6
14.1
11.47% -18.42%
67.1B
18.9B
10.69% 8.01%
38.21
3.25
-6.81% -14.96%
61.8B
12.3B
11.14% 17.68%
69.9
5.01
10.11% 51.89%
43.9B
5.4B
8.87% -30.30%
30.09
8.18
5.29% -1.25%
MID-CAP
6.7B
998.4M
15.24% 17.79%
44.21
6.87
6.04% -19.01%
6.4B
806.4M
33.98% -14.84%
-331.15
7.96
20.10% -221.96%
3.9B
380.1M
-8.48% 5.83%
-29.57
10.69
18.85% -63.58%
3.6B
790.7M
-16.73% -66.49%
-273.58
4.7
19.65% -412.22%
SMALL-CAP
1.6B
126.8M
26.44% 24.39%
-26.38
14.01
34.44% -10.05%
1.1B
291.9M
9.49% -7.06%
-6.57
3.67
52.45% -57.74%
1.0B
795.9M
17.05% -10.97%
-131.34
1.33
8.11% 182.50%
606.7M
236.2M
-6.64% -29.40%
-16.43
2.57
-8.79% -175.19%

Financials for ICU Medical

Income Statement (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Revenue14.7%2,0431,7811,5411,3161,296
Gross Profit9.9%650592548491484
Operating Expenses17.0%669572493368357
  S&GA Expenses16.8%547468383303295
  R&D Expenses15.1%8372614746
Earnings Before Taxes-175.6%-123.95-44.9724130
Net Income-810.6%-38.83541103109
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Assets-3.0%4,4504,5904,7471,8811,839
  Current Assets0.8%1,1991,1901,1741,0301,011
    Cash Equivalents-4.6%244256329553519
  Inventory7.2%625583536290292
  Net PPE-1.7%656668674468458
  Goodwill-3.6%1,3701,4211,5274333
  Current Liabilities0.6%489486494201185
    LT Debt, Current27.9%241914--
    LT Debt, Non Current-0.4%1,6301,6361,642--
Shareholder's Equity-3.5%2,0132,0862,1791,6161,590
  Retained Earnings-1.5%853866874912892
  Additional Paid-In Capital1.0%1,3231,3101,306721711
Accumulated Depreciation-437----
Shares Outstanding0.3%2424242121
* denotes actual numbers (not divided by Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Cashflow From Operations-77.5%2299215268263
  Share Based Compensation6.4%3734332725
Cashflow From Investing0.4%-1,918.41-1,926.97-1,939.56-90.69-98.65
Cashflow From Financing0.1%1,6321,6311,635-16.873
  Buy Backs-8

Risks

What is the probability of a big loss on ICUI?

61.9%


Probability that ICU Medical stock will be more than 20% underwater in next one year

42.7%


Probability that ICU Medical stock will be more than 30% underwater in next one year.

22.7%


Probability that ICU Medical stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does ICUI drawdown profile look like?

Y-axis is the maximum loss one would have experienced if ICU Medical was unfortunately bought at previous high price.

Returns

Cumulative Returns on ICUI

10.5%


10-Year Cumulative Returns

5.0%


7-Year Cumulative Returns

-5.2%


5-Year Cumulative Returns

-4.4%


3-Year Cumulative Returns

What are the long-term rolling returns for ICUI?

FIve years rolling returns for ICU Medical.

Which funds bought or sold ICUI recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2022-11-22
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
NEW
-
456,000
456,000
-%
2022-11-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
REDUCED
-1.58
-418,000
3,839,000
0.01%
2022-11-21
FourThought Financial, LLC
UNCHANGED
-
-
4,000
-%
2022-11-17
M&T Bank Corp
ADDED
5.57
13,000
728,000
-%
2022-11-16
CAPTRUST FINANCIAL ADVISORS
SOLD OFF
-100
-217,000
-
-%
2022-11-16
GLENMEDE TRUST CO NA
REDUCED
-88.85
-10,651,000
1,211,000
0.01%
2022-11-16
Retirement Systems of Alabama
REDUCED
-0.6
-389,000
3,958,000
0.02%
2022-11-15
KB FINANCIAL PARTNERS, LLC
UNCHANGED
-
-1,000
8,000
-%
2022-11-15
BNP PARIBAS ARBITRAGE, SNC
REDUCED
-47.25
-219,695
205,418
-%
2022-11-15
ALLIANCEBERNSTEIN L.P.
REDUCED
-0.81
-455,000
4,526,000
-%

1–10 of 46

Latest Funds Activity

Are funds buying ICUI calls or puts?
Are funds bullish or bearish(Calls - Puts)?
No. of funds that own ICUI

ICU Medical News

Armenian Reporter

Bank of Montreal Can Has $1.82 Million Stock Position in ICU Medical, Inc. (NASDAQ:ICUI).18 hours ago

ICUI Fair Value

Recent SEC filings of ICU Medical

View All Filings
Date Filed Form Type Document
Nov 15, 2022
4
Insider Trading
Nov 07, 2022
8-K
Current Report
Nov 07, 2022
10-Q
Quarterly Report
Sep 21, 2022
4
Insider Trading

Latest Insider Trading transactions for ICUI

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-11-15
Sanzone Virginia Ruth
SOLD
-52,039
160.12
-325
VP, General Counsel
2022-09-21
LOPEZ GEORGE A
ACQUIRED
4,914,610
61.76
79,576
-
2022-05-23
Jain Vivek
GIFTED
-
-
-30
Chairman and CEO
2022-05-13
FINNEY ELISHA W
GIFTED
-
-
-743
-
2022-05-12
Sanzone Virginia Ruth
SOLD
-130,170
173.56
-750
VP, General Counsel
2022-05-12
FINNEY ELISHA W
SOLD
-37,005
170.53
-217
-
2022-05-12
LOPEZ GEORGE A
BOUGHT
4,467,260
172.915
25,835
-
2022-05-11
FINNEY ELISHA W
ACQUIRED
-
-
433
-
2022-05-11
Hernandez Laurie
ACQUIRED
-
-
352
-
2022-05-11
Greenberg David C.
ACQUIRED
-
-
433
-

1–10 of 50

Vivek Jain
8500
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoClave and ChemoLock closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. The company offers infusion pumps under the Plum 360 and LifeCare PCA brands; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; and related professional services. It also provides critical care products, such as Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.

ICUI Income Statement

2022-09-30
Condensed Consolidated Statements of Income - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
REVENUES:    
Revenue from Contract with Customer, Excluding Assessed Tax$ 597,857$ 336,060$ 1,701,983$ 975,783
Cost of goods sold411,461208,2691,179,167611,783
Gross Profit186,396127,791522,816364,000
OPERATING EXPENSES:    
Selling, general and administrative153,45274,815465,412221,127
Research and development23,10512,23869,53834,332
Restructuring, strategic transaction and integration14,3652,35861,7958,994
Change in fair value of contingent earn-out(4,059)0(31,253)0
contract settlement000127
TOTAL OPERATING EXPENSES186,86389,411565,492264,580
(LOSS) INCOME FROM OPERATIONS(467)38,380(42,676)99,420
Interest Expense(21,151)(168)(51,068)(492)
OTHER (EXPENSE) INCOME, net311(287)782921
(Loss) Income from Continuing Operations before Income Taxes, Noncontrolling Interest(21,307)37,925(92,962)99,849
BENEFIT (PROVISION) FOR INCOME TAXES8,099(6,844)34,212(16,639)
NET (LOSS) INCOME$ (13,208)$ 31,081$ (58,750)$ 83,210
NET INCOME PER SHARE    
Basic (in dollars per share)$ (0.55)$ 1.47$ (2.47)$ 3.93
Diluted (in dollars per share)$ (0.55)$ 1.43$ (2.47)$ 3.83
WEIGHTED AVERAGE NUMBER OF SHARES    
Basic (in shares)23,90821,21423,82821,189
Diluted (in shares)23,90821,73023,82821,735

ICUI Balance Sheet

2022-09-30
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
CURRENT ASSETS:  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents$ 243,879$ 552,827[1]
Short-term investment securities2,91914,420[1]
TOTAL CASH, CASH EQUIVALENTS AND INVESTMENT SECURITIES246,798567,247[1]
Accounts receivable, net of allowance for doubtful accounts212,845105,894[1]
Inventories625,268290,235[1]
Prepaid income taxes20,17019,586[1]
Prepaid expenses and other current assets94,28346,847[1]
TOTAL CURRENT ASSETS1,199,3641,029,809[1]
PROPERTY AND EQUIPMENT, net656,383468,365[1]
Operating Lease, Right-of-Use Asset76,43839,847[1]
Long-term investment securities1,8314,620
GOODWILL1,369,71743,439[1]
INTANGIBLE ASSETS, net1,020,658188,311[1]
Deferred Income Tax Assets15,48242,604
OTHER ASSETS110,60463,743[1]
TOTAL ASSETS4,450,4771,880,738[1]
CURRENT LIABILITIES:  
Accounts payable205,04281,128[1]
Accrued liabilities244,303118,195[1]
Long-term Debt, Current Maturities24,3750
Income tax liability15,0141,454[1]
Contingent earn-out liability3000
TOTAL CURRENT LIABILITIES489,034200,777[1]
Contingent Earn-Out Liability, Noncurrent25,9422,589[1]
Long-term Debt, Excluding Current Maturities1,629,8490
Other long-term liabilities119,25141,830
DEFERRED INCOME TAXES153,5991,490[1]
INCOME TAX LIABILITY19,99718,021[1]
COMMITMENTS AND CONTINGENCIES00[1]
STOCKHOLDERS' EQUITY:  
Convertible preferred stock, $1.00 par value Authorized-500 shares; Issued and outstanding - none00[1]
Common stock, $0.10 par value - Authorized-80,000 shares; Issued 23,899 shares at June 30,2022 and 21,280 shares at December 31, 2021 and outstanding 23,898 shares at June 30, 2022 and 21,280 shares at December 31, 20212,3982,128[1]
Additional paid-in capital1,323,178721,412[1]
Treasury Stock, at cost (12,684 and 119 shares, respectively)(126)(27)[1]
Retained earnings853,037911,787[1]
Accumulated other comprehensive loss(165,682)(19,269)[1]
TOTAL STOCKHOLDERS' EQUITY2,012,8051,616,031[1]
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY$ 4,450,477$ 1,880,738[1]
[1]December 31, 2021 balances were derived from audited consolidated financial statements.